US Stock MarketDetailed Quotes

Corcept Therapeutics (CORT)

Watchlist
  • 57.080
  • +5.920+11.57%
Close May 13 16:00 ET
  • 56.990
  • -0.090-0.16%
Post 16:06 ET
6.13BMarket Cap163.09P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Corcept Therapeutics (CORT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
4.89%164.9M
12.79%761.41M
11.12%202.13M
13.75%207.64M
18.70%194.43M
7.09%157.21M
39.94%675.04M
34.33%181.89M
47.69%182.55M
39.15%163.8M
Operating revenue
4.89%164.9M
12.79%761.41M
11.12%202.13M
13.75%207.64M
18.70%194.43M
7.09%157.21M
39.94%675.04M
34.33%181.89M
47.69%182.55M
39.15%163.8M
Cost of revenue
19.98%2.88M
19.25%12.98M
-13.90%2.55M
60.31%4.6M
36.01%3.43M
-5.21%2.4M
67.91%10.88M
57.49%2.96M
74.29%2.87M
60.36%2.52M
Gross profit
4.66%162.02M
12.69%748.43M
11.54%199.58M
13.00%203.04M
18.43%191M
7.30%154.81M
39.56%664.16M
34.00%178.93M
47.33%179.68M
38.86%161.27M
Operating expense
39.78%211.62M
33.46%703.63M
26.95%195.09M
44.89%192.82M
30.75%164.32M
31.91%151.4M
43.02%527.21M
50.87%153.67M
46.60%133.08M
45.20%125.68M
Selling and administrative expenses
60.33%145.36M
60.08%448.73M
56.21%130.24M
68.12%123.98M
55.15%103.85M
61.12%90.66M
52.13%280.32M
76.82%83.37M
62.93%73.75M
54.65%66.94M
Research and development costs
9.11%66.27M
3.25%254.91M
-7.74%64.86M
16.03%68.85M
2.94%60.47M
3.81%60.74M
33.92%246.89M
28.50%70.3M
30.36%59.34M
35.74%58.75M
Operating profit
-1,552.02%-49.6M
-67.29%44.8M
-82.24%4.49M
-78.07%10.22M
-25.05%26.68M
-88.42%3.42M
27.66%136.95M
-20.23%25.26M
49.46%46.6M
20.31%35.59M
Net non-operating interest income expense
-21.22%4.89M
-11.72%21.67M
-19.04%5.42M
-20.82%5.02M
-16.44%5.02M
12.91%6.2M
42.07%24.54M
30.31%6.7M
21.83%6.35M
79.38%6M
Non-operating interest income
-21.22%4.89M
-11.72%21.67M
-19.04%5.42M
-20.82%5.02M
-16.44%5.02M
12.91%6.2M
42.07%24.54M
30.31%6.7M
21.83%6.35M
79.38%6M
Other net income (expense)
Special income (charges)
----
----
----
----
----
----
--0
----
----
----
Income before tax
-564.91%-44.72M
-58.84%66.46M
-68.99%9.91M
-71.21%15.24M
-23.81%31.69M
-72.51%9.62M
29.65%161.49M
-13.17%31.96M
45.51%52.94M
26.32%41.6M
Income tax
-18.53%-12.95M
-263.62%-33.19M
-1,284.35%-14.38M
-177.23%-4.43M
-156.60%-3.46M
-251.14%-10.93M
10.14%20.28M
-77.74%1.21M
14.44%5.73M
13.07%6.11M
Net income
-254.58%-31.76M
-29.43%99.65M
-21.00%24.29M
-58.34%19.67M
-0.96%35.15M
-25.99%20.55M
33.04%141.21M
-1.94%30.75M
50.47%47.21M
28.92%35.49M
Net income continuous Operations
-254.58%-31.76M
-29.43%99.65M
-21.00%24.29M
-58.34%19.67M
-0.96%35.15M
-25.99%20.55M
33.04%141.21M
-1.94%30.75M
50.47%47.21M
28.92%35.49M
Minority interest income
Net income attributable to the parent company
-254.58%-31.76M
-29.43%99.65M
-21.00%24.29M
-58.34%19.67M
-0.96%35.15M
-25.99%20.55M
33.04%141.21M
-1.94%30.75M
50.47%47.21M
28.92%35.49M
Preferred stock dividends
Other preferred stock dividends
-315.83%-559K
0.34%1.48M
4.44%259K
129.19%1.48M
68.40%357K
153.88%523K
Net income attributable to common stockholders
-253.80%-31.2M
-29.74%98.17M
-21.34%23.9M
-58.54%19.36M
-1.45%34.61M
-26.26%20.29M
32.45%139.73M
-2.42%30.39M
49.78%46.69M
28.38%35.12M
Basic earnings per share
-257.89%-0.3
-29.63%0.95
-20.69%0.23
-57.78%0.19
-2.94%0.33
-29.63%0.19
32.35%1.35
-3.33%0.29
45.16%0.45
25.93%0.34
Diluted earnings per share
-276.47%-0.3
-33.33%0.82
-23.08%0.2
-60.98%0.16
-9.38%0.29
-32.00%0.17
30.85%1.23
-7.14%0.26
46.43%0.41
28.00%0.32
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 4.89%164.9M12.79%761.41M11.12%202.13M13.75%207.64M18.70%194.43M7.09%157.21M39.94%675.04M34.33%181.89M47.69%182.55M39.15%163.8M
Operating revenue 4.89%164.9M12.79%761.41M11.12%202.13M13.75%207.64M18.70%194.43M7.09%157.21M39.94%675.04M34.33%181.89M47.69%182.55M39.15%163.8M
Cost of revenue 19.98%2.88M19.25%12.98M-13.90%2.55M60.31%4.6M36.01%3.43M-5.21%2.4M67.91%10.88M57.49%2.96M74.29%2.87M60.36%2.52M
Gross profit 4.66%162.02M12.69%748.43M11.54%199.58M13.00%203.04M18.43%191M7.30%154.81M39.56%664.16M34.00%178.93M47.33%179.68M38.86%161.27M
Operating expense 39.78%211.62M33.46%703.63M26.95%195.09M44.89%192.82M30.75%164.32M31.91%151.4M43.02%527.21M50.87%153.67M46.60%133.08M45.20%125.68M
Selling and administrative expenses 60.33%145.36M60.08%448.73M56.21%130.24M68.12%123.98M55.15%103.85M61.12%90.66M52.13%280.32M76.82%83.37M62.93%73.75M54.65%66.94M
Research and development costs 9.11%66.27M3.25%254.91M-7.74%64.86M16.03%68.85M2.94%60.47M3.81%60.74M33.92%246.89M28.50%70.3M30.36%59.34M35.74%58.75M
Operating profit -1,552.02%-49.6M-67.29%44.8M-82.24%4.49M-78.07%10.22M-25.05%26.68M-88.42%3.42M27.66%136.95M-20.23%25.26M49.46%46.6M20.31%35.59M
Net non-operating interest income expense -21.22%4.89M-11.72%21.67M-19.04%5.42M-20.82%5.02M-16.44%5.02M12.91%6.2M42.07%24.54M30.31%6.7M21.83%6.35M79.38%6M
Non-operating interest income -21.22%4.89M-11.72%21.67M-19.04%5.42M-20.82%5.02M-16.44%5.02M12.91%6.2M42.07%24.54M30.31%6.7M21.83%6.35M79.38%6M
Other net income (expense)
Special income (charges) --------------------------0------------
Income before tax -564.91%-44.72M-58.84%66.46M-68.99%9.91M-71.21%15.24M-23.81%31.69M-72.51%9.62M29.65%161.49M-13.17%31.96M45.51%52.94M26.32%41.6M
Income tax -18.53%-12.95M-263.62%-33.19M-1,284.35%-14.38M-177.23%-4.43M-156.60%-3.46M-251.14%-10.93M10.14%20.28M-77.74%1.21M14.44%5.73M13.07%6.11M
Net income -254.58%-31.76M-29.43%99.65M-21.00%24.29M-58.34%19.67M-0.96%35.15M-25.99%20.55M33.04%141.21M-1.94%30.75M50.47%47.21M28.92%35.49M
Net income continuous Operations -254.58%-31.76M-29.43%99.65M-21.00%24.29M-58.34%19.67M-0.96%35.15M-25.99%20.55M33.04%141.21M-1.94%30.75M50.47%47.21M28.92%35.49M
Minority interest income
Net income attributable to the parent company -254.58%-31.76M-29.43%99.65M-21.00%24.29M-58.34%19.67M-0.96%35.15M-25.99%20.55M33.04%141.21M-1.94%30.75M50.47%47.21M28.92%35.49M
Preferred stock dividends
Other preferred stock dividends -315.83%-559K0.34%1.48M4.44%259K129.19%1.48M68.40%357K153.88%523K
Net income attributable to common stockholders -253.80%-31.2M-29.74%98.17M-21.34%23.9M-58.54%19.36M-1.45%34.61M-26.26%20.29M32.45%139.73M-2.42%30.39M49.78%46.69M28.38%35.12M
Basic earnings per share -257.89%-0.3-29.63%0.95-20.69%0.23-57.78%0.19-2.94%0.33-29.63%0.1932.35%1.35-3.33%0.2945.16%0.4525.93%0.34
Diluted earnings per share -276.47%-0.3-33.33%0.82-23.08%0.2-60.98%0.16-9.38%0.29-32.00%0.1730.85%1.23-7.14%0.2646.43%0.4128.00%0.32
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -